V. Wargon

发表

Multidrug resistance protein 4/ ATP binding cassette transporter 4: a new potential therapeutic target for acute myeloid leukemia

S. Copsel, A. Bruzzone, M. May, 2014, Oncotarget.

Gelation and structural characteristics of incompatible whey proteins/hydroxypropylmethylcellulose mixtures

V. Wargon, A. Pilosof, O. E. Pérez, 2006 .

Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters.

J. Vaqué, J. Gutkind, A. Molinolo, 2012, Cancer research.

Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters

B. Jacobsen, A. Molinolo, P. Rojas, 2015, International journal of cancer.

INMUNOHISTOQUÍMICA Y EXPRESIÓN DE RECEPTORES DE ESTRÓGENOS Y PROGESTERONA EN NEOPLASIAS MAMARIAS MALIGNAS CANINAS EN DISTINTOS ESTADIOS CLÍNICOS Immunohistochemistry and Expression of Estrogen and Progesterone Receptors in Canine Malignant Mammary Tumors in Different Clinical Stages

V. Wargon, R. Soldati, C. Lanari, 2010 .

Novel, Low Cost, Highly Effective, Handmade Steroid Pellets for Experimental Studies

A. Molinolo, M. May, V. Wargon, 2013, PloS one.

Antiprogestins in breast cancer treatment: are we ready?

A. Molinolo, P. Rojas, V. Wargon, 2012, Endocrine-related cancer.

Mifepristone inhibits MPA-and FGF2-induced mammary tumor growth but not FGF2-induced mammary hyperplasia.

A. Molinolo, V. Wargon, A. Sahores, 2010, Medicina.

Mammary carcinoma associated fibroblasts as key players in the acquisition of hormone independence interaction between progesterone receptors and fibroblast growth factor receptor 2

A. Molinolo, V. Wargon, V. Fabris, 2007 .

The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer.

A. Molinolo, V. Wargon, L. Helguero, 2009, Endocrine-related cancer.

Hypermethylation of the progesterone receptor A in constitutive antiprogestin-resistant mouse mammary carcinomas

J. Russo, V. Wargon, S. Fernandez, 2011, Breast Cancer Research and Treatment.

Inhibition of mammary tumor growth by estrogens: is there a specific role for estrogen receptors alpha and beta?

A. Molinolo, V. Wargon, S. Vanzulli, 2010, Breast Cancer Research and Treatment.

Reversal of antiprogestin resistance and progesterone receptor isoform ratio in acquired resistant mammary carcinomas

A. Molinolo, P. Rojas, V. Wargon, 2009, Breast Cancer Research and Treatment.

Expression and methylation status of female-predominant GH-dependent liver genes are modified by neonatal androgenization in female mice

V. Wargon, D. Becu-Villalobos, A. Ornstein, 2014, Molecular and Cellular Endocrinology.

Progesterone receptor isoform ratio dictates antiprogestin/progestin effects on breast cancer growth and metastases: A role for NDRG1

C. Sartorius, A. Molinolo, P. Rojas, 2021, International journal of cancer.

Responsiveness to PI3K and MEK Inhibitors in Breast Cancer. Use of a 3D Culture System to Study Pathways Related to Hormone Independence in Mice

V. Wargon, C. Lanari, V. Novaro, 2010, PloS one.